Corteva

(Dollars in millions)

| October 2025 | 1,152,982 | | $ | 62.88 | | 1,152,982 | | $ | 2,658 |
| November 2025 | 2,421,790 | 65.03 | | 2,421,790 | 2,500 |
| December 2025 | 1,062,131 | | 65.88 | | 1,062,131 | | 2,430 |
| Fourth quarter 2025 | 4,636,903 | | $ | 64.69 | | 4,636,903 | | $ | 2,430 |

1.On November 19, 2024, Corteva, Inc. announced that its Board of Directors authorized a $3 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.

28

Table Of Contents

Part II

ITEM 5.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-

42

Table of Contents

looking statements is included in the “Risk Factors” section of Corteva’s 2025 Annual Report, as modified by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Recent Developments

Proposed Separation

On October 1, 2025, the company announced its intent to pursue, subject to the approval of the Board of Directors and any required regulatory approvals, its separation into two independent publicly traded companies - one for each of its Seed and Crop Protection businesses. The transaction is intended to be a tax-free spin-off for U.S. federal income tax purposes.

2026 Restructuring Actions

On March 15, 2026, management of the company approved a restructuring program designed to align the company’s organizational structure and geographic footprint with the operational needs of each function as the company prepares for the intended separation of its businesses (the “2026 Restructuring Actions”). The restructuring actions primarily consist of workforce reductions across commercial and functional support areas and are intended to right‑size the organization and support the future standalone operating models. The restructuring actions are expected to be substantially complete by December 2026.

The 2026 Restructuring Actions are expected to contribute to the company's ongoing cost and productivity improvement efforts through achieving an estimated $115 million to $125 million of savings on a run rate basis by 2027. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for further details.

After the EPA/DOJ action against Denka and EIDP was dismissed in March 2025, a private action mirroring the government's original claims was filed, adding alleged violations of the U.S. Resource Conservation and Recovery Act and U.S. Clean Water Act; under the Separation Agreement, DuPont is defending and indemnifying the company.

At the AltEn Facility near Mead, Nebraska, the EPA and NDEE pursue investigations, response/removal actions, litigation and enforcement, and Corteva is one of six seed companies (the 'Facility Response Group') participating in NDEE's Voluntary Cleanup Program.

Bay Area Quality Management, Pittsburg Facility

In December 2025, the Bay Area Quality Management District sent a notice to the company proposing a settlement for allegations of notices of violations from 2010 to 2023 relating to emissions, equipment leaks, monitoring inspections, recordkeeping, and training, at the company’s Pittsburg, California facility.

26

Table Of Contents

Part I

ITEM 3.